Head and neck mucoepidermoid carcinoma: does AFIP histological grading correlate with rate of nodal metastases?
Mucoepidermoid carcinoma
Nodal metastasis
Salivary gland neoplasms
Journal
Oral and maxillofacial surgery
ISSN: 1865-1569
Titre abrégé: Oral Maxillofac Surg
Pays: Germany
ID NLM: 101319632
Informations de publication
Date de publication:
21 Jun 2023
21 Jun 2023
Historique:
received:
31
05
2022
accepted:
02
06
2023
medline:
22
6
2023
pubmed:
22
6
2023
entrez:
21
6
2023
Statut:
aheadofprint
Résumé
The aim of this study is to retrospectively evaluate the presentation of head and neck mucoepidermoid carcinoma at the Royal Melbourne Hospital and identify the significance of AFIP histological grading on the risk of neck metastasis and cancer free survival. This study is a retrospective cohort analysis of patients treated for head and neck mucoepidermoid carcinoma at the RMH between 2005 and 2022. Patient demographics, treatment, pathology, in particular the AFIP histological grading of the primary tumour, and outcomes were collected and tabulated. Time to recurrence was recorded, and survival outcomes were calculated with Kaplan-Meier method. Comparisons were made on different histological grading and regional metastases. Thirty-three patients were identified and thirty met the inclusion criteria. There was an age range of 18-77 years (median 54 years) with no significant sex difference. Our patients had a 94% 5-year survival and an 86% 10-year survival. Thirteen patients had elective neck dissection and 2 out of 13 (15%) of the patients had positive neck disease. Of the two patients with regional metastasis, the primary tumour was graded as intermediate and low grade. No high-grade MEC patients had regional metastasis. Mucoepidermoid carcinoma of the head and neck is associated with a good disease-specific and overall survival despite the presence of regional metastasis. The AFIP histological grading system did not have a statistically significant correlation to the incidence of nodal metastasis.
Identifiants
pubmed: 37344706
doi: 10.1007/s10006-023-01163-5
pii: 10.1007/s10006-023-01163-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. Crown.
Références
Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE (2012) Salivary gland carcinomas. Oral Maxillofac Surg 16:267–283
doi: 10.1007/s10006-012-0350-9
pubmed: 22842859
Eveson JW, Auclair P, Gnepp DR, El-Naggar AK (2005) Tumours of the salivary glands: introduction. In: Barnes L, Eveson JW, Reichart PDS (eds) Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours. IARC, Lyon, pp 212–215
Ellis MA, Garboyes EM, Day TA, Neskey DM (2017) Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: analysis of national cancer database. Oral Oncol 72:174–178
doi: 10.1016/j.oraloncology.2017.07.025
pubmed: 28797455
pmcid: 5949444
Chen MM, Roman SA, Sosa JA, Judson BA (2014) Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population level analysis of 2400 patients. Head Neck 36:158–163
doi: 10.1002/hed.23256
pubmed: 23765800
Amin BM, Edge SB, Greene FL, Byrd DR, Brookland RK AJCC cancer staging manual. 8th Edition
Saade RE, Bell D, Garcia J, Roberts D, Weber R (2016) Role of CRTC1/MAML2 translocation in the prognosis and clinical outcomes of mucoepidermoid carcinoma. JAMA Otolaryngol – Head Neck Surg 142:234–240
doi: 10.1001/jamaoto.2015.3270
pubmed: 26796488
Pooja N, Lisa MR, Justin AB, William H (2019) Mucoepidermoid carcinoma of the oropharynx: a tumour type with propensity for regional metastasis unrelated to histological grade. Hum Pathol 93:1–5
doi: 10.1016/j.humpath.2019.08.014
Byrd SA, Spector ME, Carey TE, Bradford CR, McHugh JB (2013) Predictors of recurrence and survival for head and neck mucoepidermoid carcinoma. JAMA Otolaryngol – Head Neck Surg 21:402–408
doi: 10.1177/0194599813489659
Kakarala K, Bhattacharyya N (2010) Survival in oral cavity minor salivary gland carcinoma. Otolaryngol-Head Neck Surg 143:122–126
doi: 10.1016/j.otohns.2010.02.033
pubmed: 20620630
Ramirez-Perez F, Gonzalez-Garcia R, Hernandez-Vila C, Monje-Gill F, Ruiz-Laza L (2017) Is Fine Needle Aspiration a reliable tool in the diagnosis of malignant salivary gland tumours? J Craniomaxillofac Surg 45:1074–1077
doi: 10.1016/j.jcms.2017.03.019
pubmed: 28501453
Feinstein AJ, Alonso J, Yang SE, St JM (2016) Diagnostic accuracy of fine needle aspiration for parotid and submandibular gland lesions. Otolaryngol Head Neck Surg 155(3):431–436
doi: 10.1177/0194599816643041
pubmed: 27095051
Kolude B, Lawoyin JO, Akang EEU (2001) Mucoepidermoid carcinoma of the oral cavity. J Natl Med Assoc 93:178–184
pubmed: 11405595
pmcid: 2593980
Conguista AD, Connors C, Diecidue YR (2019) Population based trends in outcome in Mucoepidermoid carcinoma of the oral cavity. J Oral Maxillofac Surg 77:e82–e83
doi: 10.1016/j.joms.2019.06.110
Nance MA, Seethala R, Wang Y, Chilosea SI, Myers EN, Johnson JT, Lai SY (2008) Treatment and survival outcomes based on histological grading in patients with Head and Neck Mucoepidermoid carcinoma. Cancer 113:2082–2089
doi: 10.1002/cncr.23825
pubmed: 18720358
Spellman J, Calzada G (2018) Mucoepidermoid carcinoma: A 23 year experience with emphasis on low grade tumours with close positive margins. JAMA Otolaryngol Head Neck Surg 158(5):889–895
doi: 10.1177/0194599817751072
Spiro RH (1986) Salivary Neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 8:177–184
doi: 10.1002/hed.2890080309
pubmed: 3744850
Rajasekaran K, Stubbs V, Chen J, Yalamanchi P, Cannady S, Bran J, Newman J (2018) Mucoepidermoid carcinoma of the parotid gland: a national cancer database study. Am J Otolaryngol 39:321–326
doi: 10.1016/j.amjoto.2018.03.022
pubmed: 29559174
Granic M, Suton P, Mueller D, Cvrljevic I, Luksic I (2018) Prognostic factors in head and neck mucoepidermoid carcinoma: experience at a single institution based on 64 consecutive patients over 28 year period. Int J Oral Maxillofac Surg 47:283–288
doi: 10.1016/j.ijom.2017.09.005
pubmed: 28969884
Akbaba S, Heusel A, Mock A, Held T, Lang K, Horener-ReiberJ FT, Katayama S, Kargus S, Reiken S, Plinkert P, Klaus H, Debus J, Adeberg S (2019) The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma of the salivary glands in the head and neck: a 15 year single centre experience. Oral Oncol 97:115–123
doi: 10.1016/j.oraloncology.2019.08.018
pubmed: 31494395
Seethala RR, Stenman G (2017) Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: tumors of the salivary gland. Head Neck Pathol 11:55–67
doi: 10.1007/s12105-017-0795-0
pubmed: 28247227
pmcid: 5340736
Auclair PL, Goode RK, Ellis GL (1992) Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 69(8):2021–2030
doi: 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7
pubmed: 1544111
Skálová A, Hyrcza MD, Leivo I (2022) Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands. Head Neck Pathol 16:40–53
doi: 10.1007/s12105-022-01420-1
pubmed: 35312980
pmcid: 9018948
Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I (2013) A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg 139(7):698–705
pubmed: 23788168
Nobis CP, Rohleder NH, Wolff KD, Wagenpfeil S, Scherer EQ, Kesting MR (2014) Head and neck salivary gland carcinomas--elective neck dissection, yes or no? J Oral Maxillofac Surg 72(1):205–210
doi: 10.1016/j.joms.2013.05.024
pubmed: 23891016